Clinical Study Results
How many participants had adverse reactions?
• There were 8.3% of participants who had adverse reactions during Part A of the study. This was 1 out of 12 participants. This participant had the adverse reaction of pain in the stomach area after taking 300 mg of AZD9977 in tablet form.
• None of the participants had adverse reactions during Part B of the study.
• None of the participants stopped treatment due to adverse reactions during the study.
How has this study helped patients and researchers?
This study helped researchers learn how different forms and doses of AZD9977 act in the body in healthy participants.
Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with AZD9977 are planned.